Tapping Into China: Digital Health Spurs Partnerships, Sales Innovation
This article was originally published in PharmAsia News
China is diving deeper into mobile health to address public health issues, and companies should embrace a more integrated industry chain where big data, partnerships and new commercial models are a must for success.
You may also be interested in...
The Chinese Society of Clinical Oncology (CSCO) annual meeting, against the background of the global pandemic, has one clear message that local researchers and players are pressing ahead to take a leadership role in cutting-edge cancer research globally.
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.
China releases technical requirements for foreign drug makers to register their chemical drugs in the country, and issues patent linkage details, which a legal expert says needs to be closely examined.